Chlorpheniramine/ Pseudoephedrine/ Dextromethorphan/ Ascorbic Acid
Indications
Registered South African indications:
- Colds and influenza
Cautions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Chlorpheniramine
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Premature infants
- Neonates
- Coadministration with monoamine oxidase inhibitors or within 14 days of their use
Cautions
- Breastfeeding
- Renal impairment
- Hepatic impairment
- Elderly
- Narrow angle glaucoma
- Urinary retention
- Prostatic hypertrophy
- Severe hypertension and cardiovascular disease
- Bronchitis
- Bronchiectasis
- Asthma
- Epilepsy
- Acute exacerbation of asthma
- Fructose intolerance
- May impair ability to drive and operate machinery
Pseudoephedrine
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Severe renal impairment
- Cardiovascular disease
- Children younger than 12 years
- Phaeochromocytoma
- Diabetes mellitus
- Hyperthyroidism
- Closed angle glaucoma
- Coadministration with monoamine oxidase inhibitors or within 14 days of their use
- Coadministration with other sympathomimetic decongestants
- Coadministration with beta blockers
Cautions
- Pregnancy
- Breastfeeding
- Mild to moderate renal impairment
- Severe hepatic impairment
- Elderly
- Enlarged prostate
- Bladder dysfunction
- Seizure disorders
Dextromethorphan
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Current or risk factors for respiratory failure
- Coadministration with monoamine oxidase inhibitors or within 14 days of their use
- Coadministration with selective serotonin reuptake inhibitors
Cautions
- Pregnancy
- Breastfeeding
- Renal impairment
- Hepatic impairment
- Chronic cough
- Asthma
- History of substance abuse
- Slow metabolisers of CYP2D6
- Atopic children
- Epilepsy
Ascorbic acid
Contraindications
- Hypersensitivity to the active ingredient or any of its excipients
- Hyperoxaluria
Cautions
- Pregnancy
- Breastfeeding
- Renal impairment
- Diabetes mellitus
- Glucose-6-phosphate dehydrogenase deficiency
- Haemachromatosis
- High doses
Adult dosage
Forms avail. in SA and covered in this monograph: syr
Colds and influenza
Nasal, sinus and eustachian tube mucosal congestion
Chlorpheniramine/ Pseudoephedrine/ Dextromethorphan/ Ascorbic acid
2/25/7.5/50 (mg/5ml)
- Oral (syr): 10ml, 6hrly
Paediatric dosage
Paed. forms avail. in SA and covered in this monograph: syr
Colds and influenza
Nasal, sinus and eustachian tube mucosal congestion
Chlorpheniramine/ Pseudoephedrine/ Dextromethorphan/ Ascorbic acid
2/25/7.5/50 (mg/5ml)
- Younger than 2 years: Not established for use
- Between 2-5 years: Oral (syr): 2.5-5ml, 8hrly
- Between 6-12 years: Oral (syr): 5-10ml, 8hrly
- Older than 12 years: See adult dosage
Special populations
Recommendations for this combination product as per highest risk category when comparing individual active ingredients
Pregnancy
Breastfeeding
Renal Impairment
- Mild to moderate: Caution; no information available (Dextromethorphan)
- Severe: Contraindicated (Pseudoephedrine)
Hepatic Impairment
Elderly
Drugs in Sport
-
Prohibited - In competition
Adverse reactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Chlorpheniramine
Central Nervous System Disorders
- Sedation
- Seizures
- Disturbances in attention
- Abnormal coordination
- Dizziness
- Headache
- Depression
- Nightmares
- Paradoxical stimulation
Cardiovascular Disorders
- Palpitations
- Tachycardia
- Arrhythmias
- Hypotension
Respiratory Disorders
- Thickening of bronchial secretions
- Tight chest
Gastrointestinal Disorders
- Nausea and vomiting
- Dry mouth
- Abdominal pain
- Diarrhoea
- Constipation
- Dyspepsia
Hepatobiliary Disorders
- Hepatitis
- Jaundice
Genitourinary Disorders
- Urinary retention
- Dysuria
Endocrine and Metabolic Disorders
- Anorexia
- Increased appetite
Musculoskeletal Disorders
- Muscle twitching
- Muscle weakness
Skin and Subcutaneous Tissue Disorders
- Exfoliative dermatitis
- Rash
- Urticaria
- Photosensitivity
Immune, Blood and Lymphatic System Disorders
- Haemolytic anaemia
- Blood dyscrasias
- Allergic reaction
- Angioedema
- Anaphylactic reactions
Sensory Disorders
- Blurred vision
- Tinnitis
Pseudoephedrine
Central Nervous System Disorders
- Hallucinations
- Insomnia
- Anxiety
- Restlessness
- Irritability
- Psychosis
- Headache
- Seizures
- Vertigo
- Ataxia
- Fatigue
- Tremor
Cardiovascular Disorders
- Tachycardia
- Palpitations
- Arrhythmias
- Hypertension
- Impaired circulation to the extremities
Respiratory Disorders
- Dry throat
- Dry nose
- Dyspnoea
- Nasal congestion
- Pharyngeal oedema
- Thickening of bronchial secretions
- Wheezing
Gastrointestinal Disorders
- Dry mouth
- Nausea and vomiting
- Anorexia
- Constipation
- Diarrhoea
- Ischemic colitis
Genitourinary Disorders
- Urinary retention
- Dysuria
Skin and Subcutaneous Tissue Disorders
- Diaphoresis
- Skin photosensitivity
- Skin rash
- Urticaria
Immune, Blood and Lymphatic System Disorders
- Anaphylaxis
- Agranulocytosis
- Haemolytic anaemia
- Thrombocytopaenia
Sensory Disorders
- Angle closure glaucoma
- Blurred vision
- Diplopia
- Tinnitus
Dextromethorphan
Central Nervous System Disorders
- Somnolence
- Psychomotor hyperactivity
- Dizziness
- Seizure
- Confusional state
- Insomnia
Respiratory Disorders
- Respiratory depression
Gastrointestinal Disorders
- Nausea and vomiting
- Diarrhoea
- Abdominal pain
Skin and Subcutaneous Tissue Disorders
- Angioedema
- Pruritus
- Rash
- Urticaria
Ascorbic acid
Central Nervous System Disorders
- Dizziness
- Fatigue
- Headache
Cardiovascular Disorders
- Flushing
Gastrointestinal Disorders
- Diarrhoea
- Nausea and vomiting
- Flank pain
- Heartburn
Endocrine and Metabolic Disorders
- Hyperoxaluria
Interactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Chlorpheniramine
- Phenytoin
- Monoamine oxidase inhibitors
- Anticholinergic agents
- Antihistamines
- Central nervous system depressants
Pseudoephedrine
- Sympathomimetic agents
- Antihypertensive agents
- Monoamine oxidase inhibitors
- Volatile anaesthetics
- Cardiac glycosides
- Anticholinergic agents
- Antidepressants
- Antipsychotics
- Doxapram
- Oxytocin
- Aluminium oxide
Dextromethorphan
- Monoamine oxidase inhibitors
- Selective serotonin reuptake inhibitors
- Central nervous system depressants
- CYP2D6 inhibitors
Ascorbic acid
- Bortezomib
- Fluphenazine
- Desferoxamine
- Copper
- Aluminium
- Aspirin
- Nicotine
- Alcohol
- Appetite suppressants
- Anticonvulsants
- Iron
- Oral contraceptives
- Tetracycline
- Oral anticoagulants
- Citrate
Monitoring
None routine
Mechanism of action
Chlorpheniramine
Chlorpheniramine acts as a competitive antagonist at H1-receptors. These histamine receptors are present in the respiratory tract, gastrointestinal tract and blood vessels thus allowing chlorpheniramine to perform its role in modulating the immune response and as a decongestant.
Pseudoephedrine
Pseudoephedrine acts mainly on alpha and also on beta adrenergic receptors. It produces vasoconstriction by acting on the alpha adrenergic receptors in the mucosa of the respiratory tract. This results in the decongestant properties of pseudoephedrine.
Dextromethorphan
Dextromethorphan is a non-opioid antitussive drug. It exerts its antitussive activity by acting on the cough centre in the medulla oblongata, raising the threshold for the cough reflex.
Ascorbic acid
Ascorbic acid, a water-soluble vitamin, is essential for formation of collagen and intercellular material, and therefore necessary for the development of cartilage, bone, teeth and for the healing of wounds. It is also essential for the conversion from folic acid to folinic acid, facilitates iron absorption from the gastro-intestinal tract, influences haemoglobin formation and erythrocyte maturation and assists in providing resistance to infections.
Dosage forms
- Syrup
Formulation
COMBINATION PREPARATIONS
Chlorpheniramine/ Pseudoephedrine/ Dextromethorphan/ Ascorbic acid
Syrup (per 5ml) 2mg/25mg/7.5mg/50mg
- Flusin DM (Pharmacare)
References
1. https://drive.google.com/drive/folders/0B27NqM_vidrmNDJURnktVWhVMVU (02/03/2012_Pharmacare_Flusin DM_syrup) **See individual monographs
Brands & products
0 products · cached snapshot- Chlorpheniramine maleate (syn. Chlorphenamine)Flusin DM
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.